POSITION OF CALCIUM-ANTAGONISTS IN ANTIHYPERTENSIVE THERAPY

[1] VERAPAMIL IN THE TREATMENT OF HYPERTENSION [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (02) : 287 - 292

[2] ANTIHYPERTENSIVE EFFECT OF CARDIOVASCULAR CA2+-ANTAGONIST IN HYPERTENSIVE PATIENTS IN ABSENCE AND PRESENCE OF BETA-ADRENERGIC-BLOCKADE [J]. AMERICAN HEART JOURNAL, 1978, 96 (02) : 218 - 226

[3] BENDER F, 1970, ARZNEI-FORSCHUNG, V20, P1310

[4] SODIUM IONS, CALCIUM-IONS, BLOOD-PRESSURE REGULATION, AND HYPERTENSION - REASSESSMENT AND A HYPOTHESIS [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 232 (05): : C165 - C173

[5] BOLLI P, 1984, J CARDIOVASC PHARM, V6, pS996

[6] BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618

[7] CLINICAL TRIAL OF HYPOTENSIVE EFFECT OF VERAPAMIL [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 95 (37) : 1871 - +

[8] REVIEW OF THE CARDIOVASCULAR ADVERSITY OF THE CALCIUM-ANTAGONIST BETA-BLOCKER COMBINATION - IMPLICATIONS FOR ANTIHYPERTENSIVE THERAPY [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 : S38 - S44

[9] BUHLER FR, 1982, J CARDIOVASC PHARM, V4, pS350

[10] PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) : 1209 - +

[1] VERAPAMIL IN THE TREATMENT OF HYPERTENSION [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (02) : 287 - 292

[2] ANTIHYPERTENSIVE EFFECT OF CARDIOVASCULAR CA2+-ANTAGONIST IN HYPERTENSIVE PATIENTS IN ABSENCE AND PRESENCE OF BETA-ADRENERGIC-BLOCKADE [J]. AMERICAN HEART JOURNAL, 1978, 96 (02) : 218 - 226

[3] BENDER F, 1970, ARZNEI-FORSCHUNG, V20, P1310

[4] SODIUM IONS, CALCIUM-IONS, BLOOD-PRESSURE REGULATION, AND HYPERTENSION - REASSESSMENT AND A HYPOTHESIS [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1977, 232 (05): : C165 - C173

[5] BOLLI P, 1984, J CARDIOVASC PHARM, V6, pS996

[6] BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618

[7] CLINICAL TRIAL OF HYPOTENSIVE EFFECT OF VERAPAMIL [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1970, 95 (37) : 1871 - +

[8] REVIEW OF THE CARDIOVASCULAR ADVERSITY OF THE CALCIUM-ANTAGONIST BETA-BLOCKER COMBINATION - IMPLICATIONS FOR ANTIHYPERTENSIVE THERAPY [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 : S38 - S44

[9] BUHLER FR, 1982, J CARDIOVASC PHARM, V4, pS350

[10] PROPRANOLOL INHIBITION OF RENIN SECRETION - SPECIFIC APPROACH TO DIAGNOSIS AND TREATMENT OF RENIN-DEPENDENT HYPERTENSIVE DISEASES [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (24) : 1209 - +